Literature DB >> 20133403

Examining the public refusal to consent to DNA biobanking: empirical data from a Swedish population-based study.

Philippe A Melas1, Louise K Sjöholm, Tord Forsner, Maigun Edhborg, Niklas Juth, Yvonne Forsell, Catharina Lavebratt.   

Abstract

OBJECTIVES: To investigate empirically the motivations for not consenting to DNA biobanking in a Swedish population-based study and to discuss the implications.
DESIGN: Structured questionnaires and semistructured interviews.
SETTING: A longitudinal epidemiological project (PART) ongoing since 1998 in Stockholm, Sweden. The DNA-collection wave took place during 2006-7. PARTICIPANTS: 903 individuals completed the questionnaire (participation rate 36%) and 23 were interviewed. All individuals had participated in both non-genetic waves of the project, but refused to contribute saliva samples during the DNA-collection wave. MAIN OUTCOME MEASURES: Motivations behind refusing to consent to DNA biobanking, with subsequent focus on participants' explanations regarding this unwillingness.
RESULTS: Public refusal to consent to DNA biobanking, as revealed by the questionnaire, was mainly explained by a lack of personal relevance of DNA contribution and feelings of discomfort related to the DNA being used for purposes other than the respective study. Interviews of individuals representing the second motivation, revealed a significant mistrust of DNA biobank studies. The underlying beliefs and attitudes were associated with concerns about integrity, privacy, suspiciousness and insecurity. However, most interviewees were supportive of genetic research per se and interpreted their mistrust in the light of distressing environmental influences.
CONCLUSION: The results suggest a need for guidelines on benefit sharing, as well as trustworthy and stable measures to maintain privacy, as a means for increasing personal relevance and trust among potential participants in genetic research. Measures taken from biobanks seem insufficient in maintaining and increasing trust, suggesting that broader societal measures should be taken.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133403     DOI: 10.1136/jme.2009.032367

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  25 in total

1.  Factors influencing public participation in biobanking.

Authors:  Mamoun Ahram; Areej Othman; Manal Shahrouri; Ebtihal Mustafa
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

Review 2.  Biobanking residual tissues.

Authors:  Peter H J Riegman; Evert-Ben van Veen
Journal:  Hum Genet       Date:  2011-08-04       Impact factor: 4.132

3.  Public perspectives regarding data-sharing practices in genomics research.

Authors:  S B Haga; J O'Daniel
Journal:  Public Health Genomics       Date:  2011-03-24       Impact factor: 2.000

4.  Genetic research participation in a young adult community sample.

Authors:  Carla L Storr; Flora Or; William W Eaton; Nicholas Ialongo
Journal:  J Community Genet       Date:  2014-06-20

5.  Contrasting the ethical perspectives of biospecimen research among individuals with familial risk for hereditary cancer and biomedical researchers: implications for researcher training.

Authors:  Gwendolyn P Quinn; Alexis Koskan; Ivana Sehovic; Tuya Pal; Cathy Meade; Clement K Gwede
Journal:  Genet Test Mol Biomarkers       Date:  2014-04-30

6.  Participation in Genetic Research: Amazon's Mechanical Turk Workforce in the United States and India.

Authors:  Susan W Groth; Ann Dozier; Margaret Demment; Dongmei Li; I Diana Fernandez; Jack Chang; Timothy Dye
Journal:  Public Health Genomics       Date:  2016-11-04       Impact factor: 2.000

7.  Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing.

Authors:  Michelle M Mello; Van Lieou; Steven N Goodman
Journal:  N Engl J Med       Date:  2018-06-07       Impact factor: 91.245

8.  Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies.

Authors:  Beth A Tarini; John D Lantos
Journal:  Per Med       Date:  2013-01-01       Impact factor: 2.512

9.  Potential bias in the bank: what distinguishes refusers, nonresponders and participants in a clinic-based biobank?

Authors:  J L Ridgeway; L C Han; J E Olson; K A Lackore; B A Koenig; T J Beebe; J Y Ziegenfuss
Journal:  Public Health Genomics       Date:  2013-04-12       Impact factor: 2.000

10.  Barriers and Strategies to Participation in Tissue Research Among African-American Men.

Authors:  Bettina F Drake; Danielle Boyd; Kimberly Carter; Sarah Gehlert; Vetta Sanders Thompson
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.